ABSTRACT The Saccharomyces cerevisiae type 2C protein phosphatase Ptc1 is required for a wide variety of cellular functions, although only a few cellular targets have been identified. A genetic screen in search of mutations in protein kinase-encoding genes able to suppress multiple phenotypic traits caused by the ptc1 deletion yielded a single gene, MKK1, coding for a MAPK kinase (MAPKK) known to activate the cell-wall integrity (CWI) Slt2 MAPK. In contrast, mutation of the MKK1 paralog, MKK2, had a less significant effect. Deletion of MKK1 abolished the increased phosphorylation of Slt2 induced by the absence of Ptc1 both under basal and CWI pathway stimulatory conditions. We demonstrate that Ptc1 acts at the level of the MAPKKs of the CWI pathway, but only the Mkk1 kinase activity is essential for ptc1 mutants to display high Slt2 activation. We also show that Ptc1 is able to dephosphorylate Mkk1 in vitro. Our results reveal the preeminent role of Mkk1 in signaling through the CWI pathway and strongly suggest that hyperactivation of Slt2 caused by upregulation of Mkk1 is at the basis of most of the phenotypic defects associated with lack of Ptc1 function.
interacts with the N-terminal domain of Nbp2, an SH3 domaincontaining protein that serves as an adaptor for the recruitment of Ptc1 to the Pbs2-Hog1 complex, and this interaction is necessary for Ptc1 to participate in the regulation of HOGmediated signaling (Uetz et al. 2000; Ito et al. 2001; Mapes and Ota 2004) .
Cells lacking Ptc1 display many phenotypes that cannot be explained by a Hog1-dependent role of this phosphatase. For instance, these cells are sensitive to diverse cations, including calcium (likely by hyperactivation of calcineurin phosphatase), zinc, and cesium (Gonzalez et al. 2006) , as well as to alkaline pH . These are traits commonly found in mutants with impaired vacuolar function, and indeed, the ptc1 mutant displays fragmented vacuoles, mimicking those of class B vps (vacuolar protein-sorting) mutants (Bonangelino et al. 2002; Seeley et al. 2002; Sambade et al. 2005; Gonzalez et al. 2006) . Deletion of PTC1 confers a lithium (but not sodium)-sensitive phenotype. This can be attributed, at least in part, to a less effective cation extrusion, likely due to a Hog1-independent decrease in the expression of the Na + -ATPase ENA1 gene .
Ptc1 is required for the correct inheritance of organelles such as vacuoles, mitochondria, cortical endoplasmic reticulum (ER), peroxisomes, and secretory vesicles. These effects are independent of Hog1 dephosphorylation (Roeder et al. 1998; Du et al. 2006; Jin et al. 2009 ). Moreover, lack of Ptc1 results in additional phenotypic traits, such as defects in transfer RNA (tRNA) splicing and growth in nonfermentable media (Robinson et al. 1994) and, in haploid strains, cell separation defects and a random budding pattern at 37° ( Gonzalez et al. 2006) . A link between Ptc1 and the targetof-rapamycin (TOR) pathway was suggested by the increased sensitivity of ptc1 cells to rapamycin, an inhibitor of the TORC1 complex (Parsons et al. 2004; Xie et al. 2005) . Subsequent work demonstrated that Ptc1 is required for normal TOR signaling by regulating, in a HOG-independent manner, a step upstream of the Sit4 phosphatase (Gonzalez et al. 2009) . Recently, Ptc1 has been shown to dephosphorylate the Snf1 protein kinase at Thr 210 in vivo (Ruiz et al. 2013) .
Early work showed that mutations in PTC1 could suppress phenotypes derived from hypoactive pkc1 alleles (Huang and Symington 1995) , thus pointing to a link between Ptc1 and the cell-wall integrity (CWI) pathway. This pathway is composed of several membrane sensors that signal through the small GTPase Rho1 to the Pkc1 kinase. Pkc1 is the upstream element of a MAPK cascade composed by the MAPK kinase kinase (MAPKKK) Bck1 that phosphorylates two similar MAPKKs (Mkk1 and Mkk2), which, in turn, phosphorylate and activate the MAPK Slt2. Phosphorylation of Slt2 occurs at Tyr and Thr residues in a T-X-Y motif within the activation loop common to MAPKs [see Levin (2011) for a review]. In keeping with the involvement of Ptc1 in the CWI pathway, ptc1 mutants are sensitive to diverse cell-wall antagonists such as calcofluor white (CFW), Congo red, caffeine, and caspofungin (Ram et al. 1994; Markovich et al. 2004; Sharmin et al. 2014) or to other conditions that activate the CWI pathway, such as alkaline pH . In addition, the ptc1 mutation is synthetically lethal with mutations in genes that are important for cell-wall construction, such as FKS1, GAS1, and SMI1 (Lesage et al. 2004) . Despite the known crosstalk between the Slt2 and HOG pathways (Hahn and Thiele 2002; Bermejo et al. 2008) , the hypersensitivity of the ptc1 strain to cell-wall-damaging agents does not involve hyperactivation of Hog1 (Gonzalez et al. 2006) . Cells lacking Ptc1 display higher than normal amounts of active Slt2 (Du et al. 2006; Gonzalez et al. 2006) and show increased expression of diverse genes (MLP1, CRH1, and SED1) regulated by the Slt2 MAPK module (Gonzalez et al. 2006) . More recently, Nbp2 has been described to mediate the interaction between Ptc1 and different kinases, including Bck1 (Hruby et al. 2011; Stanger et al. 2012) . In agreement, elimination of Nbp2 results in increased sensitivity to cell-wall stressors. All this evidence suggests that Ptc1 could dephosphorylate members of the Slt2 pathway through this adaptor, contributing to the downregulation of the cascade, although the precise target(s) are yet unknown.
Based on the concept that the phenotypes observed in ptc1 mutants could be derived from the hyperphosphorylation of specific direct or indirect Ptc1 targets, we subjected a collection of mutants combining the absence of Ptc1 with that of nonessential genes encoding protein kinase catalytic or regulatory subunits to an array of phenotypic tests in search of genetic interactions, particularly those resulting in the rescue of a wide variety of ptc1 defects. Interestingly, only the mutation of one protein kinase gene, MKK1, contributed to the normalization of all ptc1 phenotypes tested. In this paper, we provide biochemical and genetic evidence showing that Mkk1 transmits most of the signaling through the CWI pathway and that Ptc1 directly downregulates the CWI pathway at the level of the MAPKKs. We propose that abnormal activation of the Slt2 kinase caused by deregulation of Mkk1 would be responsible for most phenotypic traits displayed by ptc1 mutant cells.
Materials and Methods

Media and growth conditions
Yeast cells were grown at 28°in YPD medium (10 g/l yeast extract, 20 g/l peptone, and 20 g/l dextrose) or, when carrying plasmids, in synthetic complete medium (Adams et al. 1997) containing 2% glucose and lacking the appropriate selection requirements. Escherichia coli DH5a cells were used as the plasmid DNA host and were grown at 37°in LB broth supplemented with 50 mg/ml of ampicillin, when required.
Strains and gene disruptions
Strains used to generate double mutants for screen purposes derive from wild-type strains BY4741 and BY4742, MAR143 (BY4741 ptc1::nat1), or MAR216 (BY4742 ptc1::nat1), generated by transformation of BY4742 wild-type cells with the ptc1::nat1 disruption cassette . Single BY4741 KanMX4 kinase deletion mutants correspond to the Saccharomyces Genome Deletion Collection (Winzeler et al. 1999 ) from EUROSCARF. A subset of double mutants (59 strains) was obtained by crossing the kinase mutants with strain MAR216. Homozygous double mutants were recovered by random spore or tetrad analysis. Thirty-four double mutants were generated by transformation with the ptc1::nat1 disruption cassette and selection with 100 mg/ml of nourseothricin (Werner BioAgents). Finally, 22 double mutants were generated by amplifying the kinase disruption cassettes from the single kanMX4 mutants and introducing them into strain MAR143. Positive clones were selected in the presence of 200 mg/ml of G418 (Calbiochem). Strains YPL14 and YPL15, carrying the disruption of PTC1 in the single mkk1 and mkk2 mutant strains, respectively (BY4741 background), were obtained by replacement of the wild-type PTC1 gene by the SnaBI/SphI ptc1::HIS3 fragment from the pGEMT-ptc1::HIS3 plasmid (see later) selected in the absence of histidine and checked by PCR with oligonucleotides FPTC1 and RPTC1. Strains AGS33 and AGS34 were prepared by transformation of the cch1::KanMX4 and mid1::KanMX4 deletion mutants, respectively, with the ptc1::nat1 disruption cassette described earlier. These specific strains are listed in Table 1 . All other yeast strains are listed in Supporting Information, Table S1 . Oligonucleotides used in this study are listed in Table S2 .
Plasmids
Overexpression of GST-Slt2 was carried out from plasmid pEGH-GST-SLT2 (Zhu et al. 2000) . Expression of PKC1 AAA and BCK1-20 was achieved using YEplac112-PKC1 A398A405A406 and pRS316-BCK1-20 (Martin et al. 2000) . Plasmids pRS416-MKK1myc, pRS416-MKK2myc, pRS416-MKK1 K250R myc, pRS416-MKK2 K243R myc (JimenezSanchez et al., 2007) , and pYES3-BCK1 CT (Sacristan-Reviriego et al. 2015) have been described previously. To overexpress GST-Ptc1 and GST-Nbp2, the PTC1 and NBP2 ORFs were, respectively, PCR amplified using genomic DNA as a template with primers FPTC1 and RPTC1 or FNBP2 and RNBP2. Then the BamHI-digested fragments were subcloned into pEG(KG) (Mitchell et al. 1993) , generating plasmids pEG(KG)-PTC1 and pEG(KG)-NBP2. To overexpress Ptc1 fused to GFP in N-and C-terminal positions, the pYES3-GFP-PTC1 and YCplG-PTC1-GFP plasmids were constructed by subcloning the BamHI-digested PTC1 ORF into pYES3-GFP (Andrés-Pons et al. 2007) and YCplG-GFP (Rodriguez-Escudero et al. 2006) , respectively. The pGEMT-ptc1::HIS3 plasmid was obtained by subcloning the SmaI-digested HIS3 ORF from plasmid p34H-HIS3 into the StuI site of plasmid pGEMT-PTC1, which was made using the same PTC1 PCR product described earlier. To construct plasmid pEG(KG)-MKK1 S386P , the MKK1 S386P ORF was amplified by PCR using the plasmid pNV7W-MKK1 P386 (Watanabe et al. 1995) as template and employing primers FMKK1 and RMKK1. The SalI-digested fragment was cloned into pEG(KG).
Plasmid pGEX-6P1-PTC1 was used to generate recombinant Ptc1 enzyme as a GST fusion. This plasmid was constructed by amplification of the PTC1 ORF with oligonucleotides PTC1_pGEX-Fw and PTC1_pGEX_Rv, digestion of the amplification fragment with SalI and BamHI, and cloning into the same sites of plasmid pGEX-6P1. Bacterial expression of GSTMkk1 was accomplished using plasmid pGEX(KG)-MKK1, as described in Jimenez-Sanchez et al. (2007) .
Phenotypic screen of the ptc1-kinase gene doublemutant collection
The collection of double mutants was analyzed for tolerance to diverse conditions by drop tests (dilutions of OD 660 = 0.05, 0.01, and 0.002) on YPD plates containing LiCl (50, 75, 100, 150, and 200 mM) , calcofluor white (1, 2.5, 5, 10, and 15 mg/ml), caffeine (2.5, 5, 7.5, 10, and 15 mM), rapamycin (2.5, 5, 7.5, 10, and 15 ng/ml), CaCl 2 (50, 100, 150, 200, and 400 mM), and ZnCl 2 (1, 2, 4, and 6 mM) or adjusted with TAPS to pH 7. 8, 7.9, 8.0, 8.1, and 8.2 . Growth on ethanol as the only carbon source was tested on YP plates containing 2% ethanol. Plates were incubated for 72 hr, and growth was recorded. For evaluation of the genetic interactions, a semiquantitative score was defined, as reported previously (Barreto et al. 2011 ) (see also Results).
b-Galactosidase reporter assays
Cells carrying plasmids pGAP1 and pMEP1 (Gonzalez et al. 2009 ), pKC201 (Alepuz et al. 1997) , pMLP1-LacZ (Garcia et al. 2009) , and pAMS366 (Stathopoulos and Cyert 1997) were grown to saturation on synthetic medium lacking uracil or, in the case of pMEP2 (Marini et al. 1997) , lacking leucine and then inoculated into 5 ml of YPD medium up to an OD 660 of 0.2. Growth was resumed until an OD 660 of 0.8 was reached. Then aliquots of 1 ml were centrifuged and resuspended in the same volume of the appropriate YPD medium (noninduced cells), YPD medium containing 200 ng/ml of rapamycin (pGAP1, pMEP1, and pMEP2), 30 mg/ml of Congo red (pMLP1-LacZ), or 0.2 M LiCl (pKC201). Growth was resumed for 60 min (pGAP1 and pKC201), 90 min (pMEP1 and pMEP2), or 180 min (pMLP1-LacZ). pAMS366-based assays were as in Gonzalez et al. (2006) . Finally, cells were collected, and b-galactosidase activity was measured (Reynolds et al. 1997) .
Flow cytometric assays
For monitoring effects on cell cycle, 10 ml of the appropriate cultures were grown up to exponential phase (OD 660 = 0.6) and split in two aliquots, and one aliquot was given 5 mg/ml of CFW. At given times, 1 ml of culture was taken and centrifuged (1800 3 g for 2 min). The supernatant was removed and the cells resuspended in 1 ml of 70% ethanol and stored at 4°for further use. Then cells were recovered by centrifugation (1800 3 g for 2 min), washed twice with 1 ml of 50 mM Tris-HCl (pH 7.8), and resuspended in 1 ml of the same solution containing 200 mg/ml of RNAse A. Samples were incubated for 2 hr at 37°, spun down, resuspended with 0.5 ml of freshly prepared pepsin solution (5 mg/ml in 50 mM HCl), and incubated at 37°for 30 min. Cells were recovered by centrifugation, washed with 1 ml of FACS buffer (200 mM Tris-HCl, pH 7.5, 211 mM NaCl, and 78 mM MgCl 2 ), and resuspended in 0.5 ml of FACS buffer plus 55 ml of a 0.5 mg/ml propidium iodide solution. Samples then were processed for FACS analysis in a FACSCalibur apparatus (BD Biosciences). Distribution of the population along the cell cycle was determined with FlowJo software (v8.7) and the Dean-Jett-Fox algorithm.
For Mlp1-GFP expression analysis, cells transformed with pMLP1-GFP (Rodriguez-Peña et al. 2008) were collected, washed twice with PBS, and then analyzed by flow cytometry in a Guava easyCyte flow cytometer (Millipore) with a laser at 488-nm excitation and a 525/30 BP emission filter (BFP). The marker was yeast cells that did not express GFP.
Glutathione Sepharose protein purification and mass spectrometry (MS) analysis Expression of GST-Slt2 from the pEGH-GST-SLT2 plasmid (GAL1 promoter) was achieved by shifting cells from synthetic medium lacking uracil with glucose to the same medium with raffinose (OD 660 = 0.6). Cultures were grown until OD 660 = 1.2-1.4, and then 2% galactose was added and growth resumed for 5-6 hr. To activate the Slt2 cascade, some cultures were subjected to alkaline pH stress (pH 8.2) for 10 min. Cultures were filtered, washed with prechilled water, snap frozen, and kept at 280°. To purify the GST-Slt2 protein, the crude protein extract (Martin et al. 2000) was incubated with 125 ml of a slurry of Glutathione Sepharose beads (Amersham Biosciences) overnight at 4°with gentle shaking. Samples were centrifuge, and the supernatant was removed. Beads were resuspended in 200 ml of lysis buffer and transferred to MultiScreen filter plates (Millipore). Proteins retained were fractionated by SDS-PAGE, followed by Coomassie staining. Tryptic peptides from the relevant bands were analyzed by MS. Phosphopeptides were enriched with the TiO 2 Enrichment Kit (Calbiochem). The resulting peptides were analyzed by matrix-assisted laser desorption/ ionization-time-of-flight (MALDI-TOF) MS, and mass spectra were recorded in the positive-ion mode on an UltrafleXtreme mass spectrometer (Bruker Daltonics) externally calibrated using a standard peptide mixture.
Immunoblotting analysis
For immunoblotting purposes, protein extracts were prepared as described previously (Martin et al. 2000; Serrano et al. 2006) . Immunodetection of glucose-6-phosphate dehydrogenase (G6PDH) and Myc-tagged proteins was carried out using polyclonal anti-G6PDH (Sigma) and monoclonal 4A6 (Millipore) antibodies, respectively. Polyclonal anti-phospho-p44/ p42 MAPK (Thr202/Tyr204) (Cell Signaling) and anti-GST (Santa Cruz Biotechnology) antibodies were used as described by Martin et al. (2000) . Immunodetection of GFP and actin was performed using monoclonal anti-GFP (Clontech) and anti-actin C4 (MP Biomedicals) antibodies. Polyclonal anti-phospho-p38 (Thr180/Tyr182) (Cell Signaling) antibody also was employed. The primary antibodies were detected using a fluorescently conjugated secondary antibody with an Odyssey Infrared Imaging System (LI-COR Biosciences).
Expression of recombinant GST-Ptc1 and GST-Mkk1
In brief, expression of recombinant GST-Ptc1 and GST-Mkk1 was made as follows: E. coli BL21 (DL3) cells transformed with plasmids pGEX-6P1-PTC1 and pGEX(KG)-MKK1, respectively, were induced with 0.1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) and grown overnight at 20°. The collected cells were disrupted by sonication (Bioruptor) in buffer M [50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 10% glycerol, 0.1% Triton X-100, 2 mM DTT, 0.5 phenylmethylsulfonyl fluoride (PMSF), and a protease inhibitor cocktail (Roche)], supplemented with 2 mM MnCl 2 in the case of GST-Ptc1 expression, and allowed to bind overnight at 4°t o equilibrated Glutathione Sepharose 4B resin (GE Healthcare), followed by extensive washing with buffer M (without protease inhibitors).
For GST-Mkk1 preparation, the beads were washed three times with buffer K [25 mM MOPS, pH 7.5, 10 mM MgCl 2 , 1 mM Na 3 VO 4 , 15 mM p-nitrophenyl phosphate (pNPP), and 50 mM b-glycerophosphate], resuspended (50% slurry) in the same buffer containing 30% glycerol, and stored at 220°until use. For Ptc1, the beads were washed extensively with buffer M (without protease inhibitors), followed by four washes with the same buffer lacking Triton X-100 and two washes with PreScission buffer (50 mM Tris-HCl, pH 7, 150 mM NaCl, 1 mM EDTA, and 1 mM DTT). The beads then were treated with PreScission Protease (50 units per milliliter of beads) overnight at 4°. The released protein was recovered with the supernatant, glycerol was added up to 10%, and samples were stored at 280°until use.
Expression and purification of recombinant Ppz1 were performed as described by Garcia-Gimeno et al. (2003) , except that induction was carried out overnight at 21°and EGTA was omitted from the lysis buffer.
In vitro dephosphorylation of Mkk1
Yeast extracts used for in vitro phosphorylation of GST-Mkk1 bound to the affinity beads were prepared as follows: 50-ml cultures (OD 660 0.8) of a slt2 deletion mutant in the BY4741 background, transformed with plasmid pRS316-Bck1-20, were subjected to heat shock (39°) for 1 hr. Cells were collected and resuspended in 450 ml of buffer L [50 mM Tris-HCl, pH 7.5, 5% glycerol, 100 mM NaCl, 0.1% Nonidet P-40, 10 mM NaF, 1 mM Na 3 VO 4 , 15 mM Na 4 P 2 O 7 , 15 mM pNPP, complete EDTA-free protease inhibitor (Roche), and 1 mM PMSF]. Then 200 ml of glass beads was added, and the cells were lysed in a FastPrep apparatus (five rounds of 20 sec at setting 5.0, storing samples for 1 min on ice between rounds). The lysate was centrifuged for 15 min at 12,000 3 g at 4°, and the supernatant was recovered and stored in aliquots at 280°.
For in vitro dephosphorylation assays of Mkk1 by Ptc1, 100 ml of the GST-Mkk1 slurry (containing approximately 13 mg of GST-Mkk1) or the equivalent amount of slurry carrying GST was mixed with 20 ml of a solution containing 125 mM MOPS (pH 7.5), 250 mM NaF, 250 mM b-glycerophosphate, and 25 mM sodium pyrophosphate; 10 ml of 200 mM MgCl 2 ; 20 ml of 1 mM ATP; 12 ml of [g-32 P]-ATP (3000 Ci/mmol, 10 mCi/ml), and 33 ml of the cell extract described earlier (450 mg of protein). The suspension was adjusted to 200 ml with water and incubated for 1 hr at 30°. Samples were centrifuged, the supernatant removed, and the beads washed twice with cold 25 mM MOPS (pH 7.5) and 50 mM NaF buffer; twice with 25 mM MOPS (pH 7.5), 100 mM NaCl, 5 mM EGTA, and 2 mM DTT buffer; and twice with buffer P (50 mM Tris-HCl, pH 7, 0.1 mM EGTA, 20 mM MnCl 2 , and 0.5 mM DTT). The beads were resuspended in 620 ml of buffer P and split into three aliquots of 200 ml. The beads were centrifuged, and the supernatant was removed to leave approximately 60 ml of total volume. One aliquot received recombinant Ptc1 (5.5 mg), the same amount of Ptc1 previously heated to 80°for 5 min, or the equivalent activity (measured using pNPP as substrate) of the recombinant yeast Ser/Thr phosphatase Ppz1 (2.1 mg). The mixtures were incubated for 90 min at 30°, and at the end of incubation, the samples were centrifuged and the supernatant removed. The beads were resuspended in sample buffer, boiled for 5 min, and subjected to SDS-PAGE. Radioactivity present in the gel was determined in a PMI System (BioRad).
Other techniques
Vacuole morphology was assessed by microscopic observation of FM4-64-treated cells as described previously (Vida and Emr 1995) . Staining of bud scars for determination of budding pattern was performed in exponential cultures that were grown at 37°for 6-8 hr. Cells were fixed with 3.7% formaldehyde for 1 hr, washed with PBS, and stained with 0.02 mg/ml of CFW (Fluorescent Brightener F-6259; Sigma).
Reagent and data availability
Strains and constructs described in this paper are available on request.
Results
Screen for protein kinase mutants suppressing the ptc1 mutant defects
Cells lacking Ptc1 exhibit a variety of phenotypes that, directly or indirectly, are likely the result of hyperphosphorylation of certain, still unknown Ptc1 substrates. We considered that examination of the effect of deleting genes encoding nonessential kinases catalytic polypeptides and regulatory subunits might shed light on this question. To this end, we prepared a collection of double mutants combining the deletion of genes encoding 104 nonessential protein kinases, two lipid kinases (FAB1 and VPS34), and nine regulatory subunits with that of PTC1 by mean of transformation with deletion cassettes or by genetic crossing (see Materials and Methods for details).
The collection of strains then was tested for eight different known phenotypes derived from the ptc1 mutation: increased sensitivity to LiCl, CaCl 2 , ZnCl 2 , CFW, caffeine, rapamycin, and high pH or inability to growth on ethanol as the only carbon source. A wide range of conditions (i.e., cations and drug concentrations) was assayed, so it was possible to assign a score for each combination of mutations. Strains in which the mutation of the kinase did not alter the ptc1 phenotype were scored as 0. Aggravation of the ptc1 phenotype was observed only in a few cases, and these strains received a score of 21 or 22 based on the observed effect. Combinations in which the absence of the kinase improved growth for a given test condition were scored based on the potency of the effect from very mild (1) to very strong (7). The cumulative results for each phenotype are shown in The collection of double ptc1-kinase mutants used for the screen is listed in Table S1 . Table 2 . As can be seen, the sensitivity to Zn 2+ ions and the cell-wall-damaging agent CFW were the phenotypes less frequently improved and more often worsened. In contrast, tolerance of the ptc1 mutant to CaCl 2 , rapamycin, high pH, and LiCl was improved by deletion of a substantial number of kinases. This effect was particularly relevant in the case of LiCl, for which 22 kinase deletions were able to substantially increase (scores 4-7) the tolerance to this toxic cation. The score matrix also was used for clustering analysis. Figure 1 represents a heat map resulting from such analysis in which seven major clusters can be observed. Cluster 7 congregates the kinase mutations that result in worsening of the majority of the phenotypes. Both isoforms of the casein kinase 1 catalytic subunit (YCK1 and YCK2) and one of the catalytic subunits of casein kinase 2 (CKA2) and its regulatory subunit (CKB1) are found in this cluster. Cluster 6 is composed of only two mutants, corresponding to BCK1 and SLT2, which lack, respectively, the MAPKKK and the downstream MAPK of the CWI response pathway ( Figure 1B) . Remarkably, cluster 1 is composed of only one mutant lacking the MKK1 gene, whose deletion results in a substantial improvement in all phenotypes tested. MKK1 encodes one of the two MAPKKs upstream of Slt2, which are known to contribute to the signaling in response to cell-wall damage. It is worth noting that Mkk1 and Mkk2 have been considered for a long time to be redundant enzymes acting on Slt2. However, the mkk2 mutant was included in cluster 3, indicating that this mutation cannot reproduce the effect of the deletion of MKK1 in the ptc1 background. This is better observed in Figure 1C , where the data corresponding to the genes involved in the three tiers of the CWI MAPK cascade are compared. To confirm this difference, we refined the phenotypic tests by directly comparing the tolerance of the wild-type strain, the ptc1 mutant, the single mkk1 and mkk2 strains, and their combination with the ptc1 mutation. As shown in Figure 2 , individual mutation of neither MKK1 nor MKK2 affected growth in the conditions tested. Mutation of MKK2 in the ptc1 background moderately improved growth at high pH and in the presence of zinc ions but had little or no effect in modifying other phenotypes derived from the lack of Ptc1. In contrast, mutation of the MKK1 isoform resulted in evident rescue of all tested ptc1 phenotypes, leading in some cases, such as rapamycin and LiCl tolerance tests, to very robust growth. These results suggest that Mkk1 and Mkk2 necessarily could not be redundant enzymes and points to the CWI pathway, and specifically to Mkk1, as a possible major target for Ptc1 function.
Examination of the effect of the MKK1 and MKK2 deletions on diverse readouts related to ptc1 sensitivity phenotypes To further confirm the differential effect of the mkk1 and mkk2 mutations in the suppression of the ptc1 mutant defects and to gain additional information on the possible functions affected, we selected several readouts related to the Li + , calcium, and rapamycin tolerance phenotypes.
The Na + -ATPase-encoding gene ENA1 is a key determinant of tolerance to toxic monovalent cations. Because the ptc1 mutant shows decreased expression of ENA1 in cells stressed with LiCl , we resorted to an ENA1-lacZ reporter (plasmid pKC201) to investigate the effect of the deletion of the kinases in the ptc1 mutant. As observed in Figure 3A , mutation of MKK1 significantly reversed (P , 0.001) the decrease in ENA1 promoter activity observed in ptc1 cells. However, deletion of MKK2 had no effect. Because toxic cation tolerance of yeast cells strongly correlates with changes in the expression of ENA1 (Arino et al. 2010) , it is conceivable that partial restoration of normal ENA1 function could explain the improvement in Li + tolerance observed in the double mkk1 ptc1 mutant (Figure 2 ). In agreement with this notion, deletion of MKK2 neither increases the activity of the ENA1 promoter in ptc1 cells nor improves tolerance to LiCl.
Lack of Ptc1 results in hyperactivation of calcineurin, and this can be demonstrated by monitoring the increase in expression from plasmid pAMS366, a lacZ reporter plasmid that carries a tandem of four calcineurin-dependent response elements (CDREs) from the calcineurin-regulatable FKS2 promoter (Gonzalez et al. 2006) . Figure 3B shows that deletion of MKK1 in the ptc1 background restored expression from pAMS366 to wild-type levels. In contrast, the activity of the synthetic promoter in the ptc1 mkk2 strain was similar to that of the ptc1 mutant, indicating that the impact on calcineurin caused by the absence of Ptc1 activity is neutralized specifically by the absence of MKK1. Remarkably, the increase in activity of the calcium-regulatable promoter caused by lack of Ptc1 was fully abolished not only by deletion of CCH1 or MID1, encoding plasma membrane highaffinity calcium channels that are believed to work together, but also by deletion of SLT2 (Figure 3B ), suggesting a role for Slt2 in the activation of calcineurin triggered by the lack of Ptc1.
Inhibition of the TOR pathway by rapamycin resulted in induction of a number of genes that are subjected to nitrogen catabolite repression, such as GAP1, encoding a general amino acid permease, and MEP1 and MEP2, encoding ammonium permeases. This induction is decreased in the ptc1 mutant (Gonzalez et al. 2009) (Figure S1 ). We tested, by using transcriptional fusions of the promoters to the lacZ reporter gene, whether further deletion of MKK1 or MKK2 would rescue normal gene expression. However, as seen in Figure S1 , neither mutation of MKK1 nor of MKK2 restored normal levels of GAP1, MEP1, or MEP2 promoter activity in the ptc1 background on rapamycin treatment, thus suggesting that the positive effect of deletion of MKK1 in ptc1 cells when the TOR pathway is inhibited is not caused by the restoration of nitrogen catabolite repression signaling. 
Removal of Mkk1 counteracts morphogenetic and vacuolar defects associated with lack of Ptc1 function
In addition to the phenotypic traits described earlier, lack of Ptc1 also provokes other deficiencies, such as cell separation defects, a random budding pattern in haploid cells at 37° ( Gonzalez et al. 2006) , and fragmented vacuoles (Bonangelino et al. 2002) . We first investigated the effect of mutation of the Slt2 upstream kinases on the budding pattern of ptc1 cells. To this end, cells were stained with CFW and examined by fluorescence microscopy. As shown in Figure 4A , lack of Mkk1 largely restored the normal budding pattern in ptc1 cells, whereas mutation of MKK2 had only a limited effect. Similarly, the cell-separation defect characteristic of the ptc1 strains is substantially eliminated by deletion of MKK1, while the effect of mutation of MKK2 was less marked ( Figure 4B ). We then examined the effect of the MKK1 and MKK2 deletions on the vacuolar phenotype of ptc1 mutants. Vacuolar morphology was monitored in cells pretreated with the fluorescent lipophilic dye FM4-64. As shown in Figure 4C , deletion of MKK1 largely normalized the vacuolar status in the ptc1 mutant. In contrast, deletion of MKK2 had no effect. We also included the bck1 ptc1 and slt2 ptc1 double mutants, lacking either the Bck1 kinase upstream Mkk1 and Mkk2 or their substrate, the Slt2 MAPK. Interestingly, in both cases, a perceptible improvement in vacuolar morphology could be observed. Collectively, all these experiments demonstrate that elimination of Mkk1 activity in cells deficient in Ptc1 function largely abolishes most of the phenotypic traits attributable to absence of the phosphatase.
Activation of the CWI pathway in ptc1 cells causes a delay in the G 2 -M transition that is attenuated by removal of Mkk1
A parallel project in our laboratory in search of high-copy suppressors of the CFW sensitivity of ptc1 cells (manuscript in preparation) identified, among others, several genes involved in promoting the G 2 -M transition (such as CLB1, MIH1, and PIN4). Prompted by these results, we subjected nonsynchronized wild-type and ptc1 cells to a low dose of CFW and monitored their DNA content by flow cytometry. As shown in Figure 4D , treatment with CFW did not affect wild-type cells but caused a marked accumulation of cells with replicated DNA in the ptc1 strain, suggesting a delay in G 2 -M transition. This delay was significantly suppressed by additional deletion of MKK1, suggesting that hyperactivation of the CWI pathway in the ptc1 mutant results in delayed G 2 -M transition and that signaling through Mkk1 markedly contributes to this effect.
Ptc1 reduces CWI signaling by acting at the MAPKK level
The genetic experiments described so far point out to the Mkk1 kinase as a possible functional target for Ptc1. Our initial attempts to demonstrate that Ptc1 directly dephosphorylates Mkk1 were frustrated by the difficulty in purifying significant amounts of in vivo phosphorylated GST-fused Mkk1 from wild-type and ptc1 cells (see later). Therefore, we further explored this possibility by epistatic analyses based on PTC1 overexpression and using the dual phosphorylation of Slt2 as a readout of pathway activation. As occurred with Hog1 phosphorylation, overexpression of Ptc1, but not the adaptor protein Nbp2, reduced the amount of phosphorylated Slt2 ( Figure 5A ) both in the absence and in the presence of Congo red, a compound that interferes with chitin organization, leading to CWI pathway stimulation (Marin et al. 2009 ). In contrast, overexpression of Ptc1 did not decrease the level of phospho-Fus3 and phospho-Kss1 of pheromonestimulated cells (data not shown), indicating that Ptc1 overexpression does not result in indiscriminate nonspecific downregulation of MAPK signaling. To activate the CWI pathway at the level of the MAPK module, we used a constitutively active version of the MAPKKK Bck1 that lacks the first 1171 amino acids (Bck1 CT ) (Sacristan-Reviriego et al. 2015) . As shown in Figure 5B , overexpression of Ptc1 was able to reduce the strong Slt2 phosphorylation promoted by Bck1 CT . Because this version does not contain the N-terminal Nbp2-binding proline-rich motif (Hruby et al. 2011) , we previously confirmed that Nbp2 is not necessary for overexpressed Ptc1 to act on the CWI pathway ( Figure  S2 ). Bck1 CT also lacks the phosphorylation sites necessary for its activation by Pkc1 (Levin et al. 1994) . Therefore, Ptc1 does not decrease Slt2 phosphorylation by promoting the dephosphorylation of Bck1. Moreover, the fact that GST-Ptc1 overexpression still reduced the Slt2 phosphorylation promoted by Bck1 CT in a pkc1 strain ( Figure 5C ) clearly shows that the target is neither Pkc1 nor Bck1 but a downstream kinase.
We next addressed whether Ptc1 acts at the level of the MAPK, as described previously for the HOG pathway (Warmka et al. 2001) . As shown in Figure 5D , overproduction of Ptc1 did not reduce Slt2 phosphorylation in a bck1 strain expressing a constitutively active Mkk1-mutated version (MKK1 S386P ) (Watanabe et al. 1995) . This clearly shows that Ptc1 is not able to directly dephosphorylate the MAPK Slt2. Together these results provide genetic evidence that Ptc1 impinges on the CWI pathway at the MAPKK level.
To clarify which MAPKK is the Ptc1 target, we used mkk1 and mkk2 mutant cells. Overexpression of Ptc1 reduced Slt2 phosphorylation in both mutant strains when the pathway was activated either by expressing constitutively active upstream components of the pathway, such as Bck1 CT ( Figure 5E ), Bck1-20 (Lee and Levin 1992) , and PKC1 R398A,R405A,K406A ( Figure S3, A and B) or by heat stress (Martin et al., 2000) ( Figure S3C ). These data indicate that despite the different pattern of genetic interactions between PTC1 and MKK1 or MKK2 shown earlier, Ptc1 is able to downregulate both CWI MAPKKs.
Mkk1, but not Mkk2, is required for the increased CWI signaling displayed by ptc1D mutants Experiments shown in Figure 5E and Figure S3 also provided evidence that the mkk1D mutant displays a lower level of Slt2 phosphorylation than mkk2D cells in all tested conditions. The same pattern also was observed under several cell-wall stresses ( Figure S4A ). The different phospho-Slt2 levels showed by mkk1 and mkk2 mutants correlate with their distinct Rlm1-mediated gene expression, as determined by using the CWI transcriptional reporter MLP1-LacZ (Garcia et al., 2009) (Figure S4B) .
Moreover, the lack of Mkk1, but not that of Mkk2, promoted a strong reduction of the high level of Slt2 phosphorylation displayed by the ptc1 mutant ( Figure 6A ). This effect was observed both in the absence and in the presence of Congo red, and it was specific for the CWI pathway because removal of neither Mkk1 nor Mkk2 showed significant influence on the increased Hog1 phosphorylation displayed by ptc1 mutant cells ( Figure 6A) . Consistently, in a ptc1 mutant Figure 3 Deletion of MKK1 normalizes decreased expression from the ENA1 and calcineurin-regulatable promoters in ptc1 mutants. (A) The indicated strains were transformed with plasmid pKC201 (pENA1) carrying a fusion of the ENA1 promoter with the lacZ gene. Cells were stressed with 0.2 M LiCl for 1 hr (black bars), and b-galactosidase activity was measured. Data are mean 6 SEM from at least 10 independent determinations. The asterisk denotes a statistically significant difference (P , 0.001) between ptc1 and ptc1 mkk1 strains. (B) Each PTC1 (+) or ptc1 (2) strain was deleted for the indicated genes. Cells were transformed with plasmid pAMS366 (pCDRE) containing four copies of a calcineurin-dependent response element (CDRE) from the FKS2 promoter, and b-galactosidase activity was determined. Data are mean 6 SEM from 6-14 experiments.
transformed with the CWI transcriptional reporter MLP1-GFP (Rodriguez-Peña et al., 2008) , only the deletion of MKK1 reduced GFP fluorescence to similar levels as those displayed by wild-type cells both in the absence and in the presence of Congo red ( Figure 6B ). All these results indicate that phosphorylation of Slt2 and consequent activation of the CWI transcriptional response are mainly mediated by Mkk1. Furthermore, expression of the wild-type but not a kinase-dead version of this MAPKK in the mkk1 ptc1 double mutant restored the high Slt2 phosphorylation level characteristic of the single ptc1 mutant ( Figure 6C ). Because the abundance of inactive Mkk1 is even higher than that of the wild-type protein, it can be concluded that the ability of Mkk1 to maintain a high Slt2 activation in ptc1 mutant cells depends on its kinase activity.
Further evidence of the major role of Mkk1 for signaling through the CWI pathway and of the influence of Ptc1 in this process was obtained by expressing a GST-Slt2 fusion version in wild-type, ptc1, mkk1, and ptc1 mkk1 double-mutant strains and shifting the cultures to high pH (8.2), which rapidly activates the CWI pathway and induces phosphorylation of Slt2 . GST-Slt2 was isolated by affinity chromatography, the samples were resolved by SDS-PAGE and stained, and the excised bands were subjected to tryptic digestion. After enrichment for phosphopeptides, samples were analyzed by MS, the peptide containing the phosphorylatable Thr and Tyr at the activation loop was identified, and the ratio of phosphorylated to total peptide was calculated. We found that the phosphorylation level of this peptide was 5.6-fold higher in ptc1 than in mkk1 cells and that deletion of MKK1 in the ptc1 mutant resulted in reduction of the phosphorylation levels to that of the single mkk1 mutant ( Figure  S5 ). These data further confirm that in the absence of Ptc1, Slt2 results in hyperactivation in response to stress in a way that essentially depends on Mkk1 function.
Together our results fit with the notion that the sensitivity of ptc1 mutants to cell-wall-altering agents is mostly due to hyperactivity of the CWI pathway, which is strongly reduced in the absence of Mkk1 (Figure 2 and Figure S3C) , and reinforces the idea that Mkk1 is more effective than Mkk2 in signaling to Slt2
The apparent difference in protein abundance between the native and kinase-dead versions of Mkk1 in a ptc1 background observed in the experiment shown in Figure 6C suggested that cells might be downregulating the level of Mkk1 as a response to the inability to inactivate the kinase by dephosphorylation. To test this possibility, wild-type, ptc1, slt2, and ptc1 slt2 cells were transformed with either centromeric or high-copy plasmids bearing epitope-tagged native Mkk1 or its equivalent kinase-dead (K250R) version. As shown in Figure  6D , when the native version of the Mkk1 kinase was expressed from a centromeric plasmid in ptc1 cells, the amount of this kinase was markedly lower than in the wild-type strain, whereas further deletion of Slt2 restored Mkk1 wild-type levels. Interestingly, the amount of Mkk1 protein did not decrease in the ptc1 background when the form devoid of kinase activity was expressed. It is important to note that, in contrast, the level of Mkk2 in the absence of Ptc1 was similar in either its active or inactive forms ( Figure 6C ). The effect of deletion of SLT2 on Mkk1 levels was particularly dramatic when MKK1 was expressed from a high-copy-number vector ( Figure 6D ). These results point to the idea that in the absence of Ptc1 and as a response to the subsequent hyperactivation of Slt2, the cell attempts to avoid an exacerbated level of Mkk1 kinase activity by decreasing the amount of Mkk1 protein.
Ptc1 dephosphorylates in vitro GST-Mkk1
The results described earlier could be explained if Ptc1 were acting directly on Mkk1 by dephosphorylating and Figure 5 Ptc1 acts on the CWI pathway at the level of the MAPKKs. (A) Western blotting analysis in the wild-type strain BY4741 transformed with pEG(KG) (GST), pEG(KG)-PTC1, or pEG(KG)-NBP2. Cells were grown to mid-log phase in raffinose-based medium, then galactose was added to a final concentration of 2% for 2 hr, and cells were treated or not (2) with Congo red (30 mg/ml) for additional 2 hr. Phospho-Slt2, phospho-Hog1, GST-fused proteins, and actin (loading control) were detected with anti-phospho-p42/44, anti-phospho-p38, anti-GST, and anti-actin antibodies, respectively. (B) Western blotting analysis performed as in A in the wild-type strain YPH499 transformed with YCplG (2) or YCplG-PTC1-GFP and pYES3 (2) or pYES3-BCK1 CT , as indicated. Ptc1-GFP was detected with anti-GFP and G6PDH (as loading control) with anti-G6PDH antibodies. (C) Western blotting analysis performed as in A in the wild-type strain CML128 and the isogenic pkc1 mutant transformed with pEG-(KG) (GST) or pEG (KG)-PTC1 and pYES3 (2) inactivating this MAPKK. To test this possibility, we expressed in E. coli Mkk1 fused to GST and purified the protein by means of glutathione agarose beads. Recombinant Mkk1 bound to the beads was phosphorylated in vitro with 32 P-labeled ATP using a yeast extract from a strain overexpressing the hyperactive Bck1-20 allele as a source of kinase activity to increase the amount of phosphorylated Mkk1. This strain also lacks Slt2 to avoid the retrophosphorylation of Mkk1 exerted by this MAPK in residues different from the conserved activation sites phosphorylated by Bck1 (Jimenez-Sanchez et al. 2007) . Phosphorylated GST-Mkk1 was then incubated with either recombinant Ptc1, the same amount of heat-inactivated Ptc1, or Ppz1, a PP1-like Ser/ Thr protein phosphatase that has been genetically related to (Lee et al. 1993; Posas et al. 1993) but is not directly involved in the CWI pathway (Merchan et al. 2004) . As can be seen in Figure 7 , after treatment with heat-inactivated Ptc1 or active Ppz1, Mkk1 appears radioactively labeled to a similar amount. In contrast, treatment with active Ptc1 results in the disappearance of most of the radioactive phosphate previously incorporated into the protein. This indicates that Ptc1 recognizes Mkk1 as a substrate and shows that this is not a common feature for yeast Ser/Thr PPases.
Discussion
Ptc1 is known to be involved in a wide variety of cellular processes, but most cellular targets for its phosphatase Figure 6 Mkk1 kinase activity is essential for ptc1 mutants to display high Slt2 activation. (A) Western blotting analysis in the wild-type strain BY4741 and the indicated isogenic mutants. Exponentially growing cells at 24°in YPD were treated or not (2) with Congo red (30 mg/ml) for 3 hr. Phospho-Slt2, phospho-Hog1, and G6PDH (loading control) were detected with anti-phospho-p42/44, anti-phospho-p38, and anti-G6PDH antibodies, respectively. (B) Expression of MLP1-GFP determined by flow cytometry in the same growth conditions and strains as in A but carrying the plasmid pMLP1-GFP. Data are mean 6 SD from three independent transformants. (C) Western blotting analysis performed as in A in the indicated mutant strains transformed with the empty vector pRS416 (V) or plasmids pRS416-MKK1myc, pRS416-MKK1 K250R myc (MKK1KD), pRS416-MKK2myc, or pRS416-MKK2 K243R myc (MKK2KD). Mkk1 and Mkk2 were detected with anti-myc antibodies. (D) The indicated strains were transformed with plasmid pRS416-MKK1myc or pRS416-MKK1 K250R myc (centromeric vector) or YEp352-MKK1myc (high-copy-number vector), and the amount of expressed Mkk1 was monitored by Western blot analysis. Ponceau staining is included for loading and transfer reference.
activity are unknown. The high number of genetic interactions of PTC1 with protein kinase genes found in our work confirms the functional broadness of this protein phosphatase. Remarkably, only the mutation of Mkk1, one of the MAPKKs of the CWI pathway, was able to substantially suppress all the phenotypes of the ptc1 mutant tested in the screen (Figure 1 and Figure 2) , as well as additional defects attributable to the ptc1 mutation (Figure 3 and Figure 4 ). This finding reinforces previous evidence linking Ptc1 to the CWI pathway (Huang and Symington 1995; Gonzalez et al. 2006; Hruby et al. 2011; Stanger et al. 2012; SacristanReviriego et al. 2015) and strongly suggests that abnormal activation of the CWI pathway is at the basis of many of the defects derived from the absence of Ptc1. It must be noted that an excessive activation of the CWI pathway can be deleterious, as observed when hyperactive alleles of Pkc1 or Mkk1 are overexpressed (Watanabe et al. 1995; Martin et al. 2000) . Based on this finding, it would be expected that deletion of components upstream (BCK1) or downstream (SLT2) of Mkk1 in the CWI MAPK module also would attenuate the ptc1 phenotypes. However, this is not the case for the sensitivity to CFW, caffeine, or high pH because the compensatory response mediated by the CWI pathway itself is essential for cell viability under cell-walldamaging conditions. The different effect of the MKK1 deletion would be attributable to the existence of another MAPKK, Mkk2, whose residual activity is able to sufficiently activate Slt2 to cope with cell-wall stress conditions but not to convey a deleterious hyperactivation of the CWI pathway. This fits with the heat map presented in Figure 1 , in which BCK1 and SLT2 cluster together, but distant from MKK1.
The results presented here strongly support the idea that Mkk1 conveys most of the signaling flow through the pathway, as deduced from the observations that (1) elimination of Mkk1 but not Mkk2 attenuates a large variety of ptc1 defects, (2) lack of Mkk1 gives rise to a great reduction in both Slt2 phosphorylation and its derived transcriptional response, which is not observed in the mkk2 strain, and (3) cells lacking Ptc1 avoid accumulation of the native version of Mkk1 but tolerate the inactive version of the kinase, and elimination of Slt2 restores wild-type Mkk1 protein levels. This evidence confirms initial studies suggesting that Mkk1 could be a stronger Slt2 activator than Mkk2 (Martin et al. 2000) . The preeminent role of Mkk1 over Mkk2 cannot be attributed to a higher abundance of Mkk1 because evaluation of the data collected at the PaxDb (Wang et al. 2015) indicates that, in most studies, Mkk2 cellular protein levels are found to be similar to or even higher than those of Mkk1. Therefore, alternative possibilities must be considered (i.e., different specific activity or distinct subcellular localization). In any case, the major role of Mkk1 as activating the CWI pathway is observed under all conditions tested, and therefore, it is likely based on intrinsic functional properties of this MAPKK and not dependent on mechanisms operating under specific stimuli.
Our results support a model in which many cellular phenotypes described for the ptc1 mutant could be attributable to an anomalous activation of the Slt2 pathway derived from the incapacity to properly dephosphorylate and downregulate Mkk1. For instance, activation of the CWI pathway by eliminating Msg5, the major Slt2 phosphatase, also results in increased sensitivity to cell-wall stress (Flandez et al. 2004) . Moreover, the cortical ER inheritance defect displayed by ptc1 cells is suppressed by either loss of Slt2 or inhibition of the CWI pathway (Du et al. 2006; Li et al. 2013) . In addition, Ptc1-dependent inactivation of Slt2 is also needed for mitochondrial inheritance (Li et al. 2010) , suggesting that hyperactivation of this pathway is at the basis of these defects. Our findings also emphasize the multiple regulatory roles of the CWI pathway and stress the importance of an appropriate negative modulation of this route for cellular homeostasis. An example would be the impact of Ptc1 on calcium homeostasis. We reported that a major effect derived from the lack of Ptc1 was a calcineurin-mediated increase in sensitivity to calcium ions and an increased expression of calcineurindependent genes (Gonzalez et al. 2006) , and it is shown here that these effects are largely abolished by deletion of MKK1 (Figure 2 and Figure 3B ). We propose that the impact of the lack of Ptc1 on calcium homeostasis is the result of hyperactivation of the Slt2 pathway. It can be conceived that augmented Slt2 pathway activity would result in increased entry of calcium ions from the medium. This notion is sustained by (1) the early observation that Slt2 activation is required for calcium entry through the cell membrane Mid1 and Cch1 transporters (Bonilla and Cunningham 2003) , (2) the recent evidence that a ptp2 msg5 phosphatase double mutant, which has an increased level of activated Slt2, is also highly sensitive to calcium in a calcineurin-dependent fashion (Lavina et al. 2013) , and (3) our own finding that removal of either Slt2 or the calcium plasma membrane transporters eliminates activation of a calcium-regulatable reporter displayed by ptc1 cells ( Figure 3B ). It is also known that deletion of both PTP2 and MSG5 causes vacuolar fragmentation (Hermansyah et al. was incubated with equivalent amounts of heat-inactivated Ptc1 (Ptc1*), active Ptc1, or Ppz1. The beads were resuspended in sample buffer and boiled, and the supernatant was subjected to 8% SDS-PAGE. Radioactivity was detected by means of a PMI system (BioRad). Recombinant GST was also included in the experiment as a control. Coomassie staining of the relevant section of the gel shows the amount of GST-Mkk1 present in the different lanes.
2009), as the ptc1 mutation does, suggesting that this also might be caused by Slt2 hyperactivation. Because the yeast vacuole is the major reservoir for intracellular calcium, vacuolar fragmentation could exacerbate the effect of enhanced calcium entry. However, vacuolar fragmentation caused by the ptc1 mutation simply could be a physiologic response to the enhanced entry of calcium, leading to improved sequestration of the cation at the vacuole by maximizing its surfacevolume ratio (Kane 2006 ) because this phenotype also has been observed in mutants with constitutive high levels of cytosolic calcium (Kellermayer et al. 2003) .
The genetic and biochemical analyses presented in Figure  5 indicate that Ptc1 acts at the level of the MAPKK tier of the CWI MAPK module. We also provide evidence that Ptc1 can dephosphorylate in vitro recombinant Mkk1 previously phosphorylated by a yeast extract prepared from cells with an activated CWI pathway. This evidence, together with the large number of specific genetic interactions observed between PTC1 and MKK1, allows us to postulate that Ptc1 is likely a major Mkk1 phosphatase in vivo. Note, however, that whereas our data also suggest that Ptc1 is able to dephosphorylate Mkk2, the limited influence of this MAPKK in CWI signaling would explain the scarce relevance of such negative regulation. Protein phosphatases are the main negative regulators of MAPK pathways, and so far, all the known phosphatases acting on yeast MAPK modules dephosphorylate the MAPK (Martin et al. 2005) . For instance, in the HOG pathway, Ptc1 is recruited to the MAPKK Pbs2 through the adaptor Nbp2 to act on the MAPK Hog1 (Mapes and Ota 2004) . In contrast, in the CWI pathway, Ptc1 would be recruited by Nbp2 to the MAPKKK Bck1 to dephosphorylate the MAPKKs. Therefore, our results highlight the ability of this protein phosphatase to dephosphorylate a variety of elements of MAPK pathways in yeast, as occurs in mammals, where PP2C phosphatases negatively regulate the three different components of the MAPK signaling module (Lammers and Lavi 2007) .
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Figure S3: Ptc1 acts on both Mkk1 and Mkk2. A) Western blotting analysis of cell extracts from the wild type strain YPH499 and the isogenic mkk1∆ and mkk2∆ strains transformed with pYES3-GFP or pYES3-GFP-PTC1 and pRS316 or pRS316-BCK1-20. Cells were grown to mid-log phase in raffinose-based medium, then galactose was added to a final 2% for 2 h. Phospho-Slt2, GFP-fused proteins, and G6PDH (loading control) were detected with anti-phospho-p42/44, anti-GFP and anti-G6PDH antibodies, respectively. B) Western blotting analysis in the same strains as in A, transformed with plasmids transformed with pEG-(KG) or pEG(KG)-PTC1 and YCplac112 (-) or YCplac112-PKC1 AAA . C) Western blotting in the wild type strain BY4741 and the isogenic mkk1∆ and mkk2∆ strains, transformed with pEG-(KG) or pEG(KG)-PTC1. Cells were cultured at 24ºC (-) or at 39 ºC (+) for one hour. Figure 6 in WT strain BY4741 and the isogenic mkk1∆ and mkk2∆ mutants. Exponentially growing cells at 24 °C in YPD were treated or not with Congo red (30μg/ml) or zymolyase 100T (0.8 U/ml) for 3 h. B) Expression of MLP1-LacZ was determined as β-galactosidase activity in cells of the same strains as in A, but carrying the plasmid p-MLP1-LacZ, grown in the absence (white bars) or the presence (black bars) of Congo Red. Data are mean ± SD from three independent experiments in triplicate. C) 10-fold dilution series of the wild type strain BY4741 and the indicated isogenic mutants were spotted on YPD and YPD containing Congo Red (75μg/ml) or zymolyase 20T (200 μg/ml).
Plates were incubated at 24ºC and growth was monitored after 48 h. 
